Stephen Davis
Chief Executive Officer at ACADIA PHARMACEUTICALS INC.
Net worth: 3 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Stephen Biggar | M | 53 | 13 years | |
| Julian Baker | M | 57 |
Neurogen Corp.
 Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.
Trimeris, Inc.
 Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 22 years |
| Richard Fair | M | 55 | 7 years | |
| Kimberly Manhard | F | 64 | 10 years | |
| Edmund Harrigan | M | 71 | 9 years | |
| James Daly | M | 63 | 8 years | |
| Craig Collard | M | 58 | 1 years | |
| Craig Johnson | M | 62 |
Ardea Biosciences, Inc.
 Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Adam Morgan | M | 45 | 1 years | |
| Brendan Teehan | M | 56 | 6 years | |
| Elizabeth Garofalo | M | 66 | 4 years | |
| Mark Schneyer | M | 50 | 4 years | |
| Bob Mischler | M | - | 9 years | |
| Albert Kildani | M | - | 1 years | |
| Sharmila Dissanaike | M | 49 | 3 years | |
| Katherine Bishop | M | 58 | 3 years | |
| Laura Brege | F | 66 | 16 years | |
| Don Soland | M | 65 | 9 years | |
| Susan Rodriguez | F | 60 | 3 years | |
| Jennifer J. Rhodes | F | 53 | - | |
| Julie Fisher | F | - | 6 years | |
| Sanjeev Pathak | M | - | 3 years | |
| Holly Valdiviez | F | - | 2 years | |
| Kevin Oliver | M | - | 1 years | |
| Rob Ackles | M | - | 10 years | |
| Jenny Chaplin | F | - | 6 years | |
| Kazenelson Deb | F | - | - | |
| Scott Edelman | M | 61 |
Milbank LLP
 Milbank LLP Miscellaneous Commercial ServicesCommercial Services Milbank LLP provides legal services. It serves corporate, finance, financial restructuring, litigation and arbitration, securities, capital markets, trusts, estates, and exempt organizations, and tax markets. The company was founded in 1866 and is headquartered in New York, NY. | 30 years |
| Adora Ndu | M | 43 | 2 years | |
| Dave Maggio | M | 64 | - | |
| James Kihara | M | - | 4 years | |
| Parag V. Meswani | M | - | 2 years | |
| Ponni Subbiah | M | - | 5 years | |
| Sean T. Ristine | M | 54 | 10 years | |
| James Sligar | M | - |
Milbank LLP
Milbank LLP Miscellaneous Commercial ServicesCommercial Services Milbank LLP provides legal services. It serves corporate, finance, financial restructuring, litigation and arbitration, securities, capital markets, trusts, estates, and exempt organizations, and tax markets. The company was founded in 1866 and is headquartered in New York, NY. | 33 years |
| Benir Ruano | M | - | 2 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Felix Baker | M | 55 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT.
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE.
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 16 years |
| Kevin Tang | M | 57 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC.
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 26 years |
| Barry Quart | M | 67 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 16 years |
| Henry Fuchs | M | 66 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 16 years |
| John W. Poyhonen | M | 64 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Alan Musso | M | 62 | 4 years | |
| Elena Ridloff | F | 44 | 3 years | |
| Uli Alf Hacksell | M | 74 | 15 years | |
| June Almenoff | M | 67 | 4 years | |
| Kevin M. Slawin | M | 63 | 13 years | |
| Wendy Dixon | M | 68 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 4 years |
| Thomas J. Farrell | M | 60 | 11 years | |
| Harry Penner | M | 78 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 8 years |
| Robert H. Rosen | M | 68 | 7 years | |
| William H. Koster | M | 79 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 7 years |
| John B. Whelan | M | 62 | 4 years | |
| Sanj Patel | M | 54 | 7 years | |
| Gregory H. Turnbull | M | 85 | 26 years | |
| Andrew L. Graham | M | - |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 7 years |
| Tom Paulson | M | 77 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 5 years |
| Jon Stonehouse | M | 63 | 10 years | |
| Srdjan Stankovic | M | 67 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 9 years |
| Martin Mattingly | M | 66 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 5 years |
| Glenn F. Baity | M | 54 | 14 years | |
| James R. Thomas | M | 73 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 2 years |
| James A. Nash | M | 73 | - | |
| Esmé c. Smith | F | 52 | - | |
| Mark Goldberg | M | 69 | 6 years | |
| Mary Gray | M | 71 | 11 years | |
| Annemarie B. Moseley | M | 68 | 6 years | |
| Christian Waage | M | 57 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 4 years |
| Reid Huber | M | 52 | 10 years | |
| Shane Ward | M | 49 | 2 years | |
| Todd Young | M | 52 | 2 years | |
| Jesse Hollingsworth | M | - | - | |
| James Farrell Brown | M | 59 | 11 years | |
| James M. Mackay | M | - |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 5 years |
| Darrell Ward Jayroe | M | - |
Southern Nazarene University
| 7 years |
| Amanda Morgan | F | - | - | |
| Lisa Peraza | F | 47 | 10 years | |
| David M. Spencer | M | 61 | 15 years | |
| Torsten Erik Rasmussen | M | 78 | 17 years | |
| Austin Kim | M | 60 | 6 years | |
| William McDowall Wells | M | 63 | 4 years | |
| Suzanne H. Woolsey | M | 83 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 11 years |
| Fred Eshelman | M | 76 | 5 years | |
| Peter Wirth | M | 73 | 3 years | |
| Leslie L. Iversen | M | 86 | 18 years | |
| Thomas Malley | M | 55 | 9 years | |
| Brian Drazba | M | 63 | 4 years | |
| Jack S. Remington | M | 93 |
Ardea Biosciences, Inc.
Ardea Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Ardea Biosciences, Inc. is a biotechnology company which is focused on the development of small-molecule therapeutics for the treatment of serious diseases. The company was founded in January 1994 and is headquartered in Wilmington, DE. | 15 years |
| Paul Goddard | M | 74 | 12 years | |
| Peter Corr | M | 76 | 4 years | |
| Michael T. Borer | M | 65 | 11 years | |
| Marshall H. Woodworth | M | 66 | 3 years | |
| Thomas Tisch | M | 69 | 3 years | |
| Stephen W. Kaldor | M | 62 | 4 years | |
| Thomas A. Pitler | M | 65 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | - |
| Frank B. McGuyer | M | 72 | 9 years | |
| Kevin Kotler | M | 53 | - | |
| Jeffrey Dill | M | 62 |
Neurogen Corp.
Neurogen Corp. Pharmaceuticals: MajorHealth Technology Neurogen Corp. operated as a drug discovery and development company. The company was headquartered in Branford, CT. | 1 years |
| E. Lawrence Hill | M | 73 |
Trimeris, Inc.
Trimeris, Inc. Pharmaceuticals: MajorHealth Technology Trimeris, Inc. develops therapeutics for viral diseases. It is a biopharmaceutical company engaged in the discovery, development and commercialization of novel therapeutic agents for the treatment of viral disease. The core technology platform of fusion inhibition is based on blocking viral entry into host cells. The company was founded in 1993 and is headquartered in Durham, NC. | 1 years |
| Alan K. Smith | M | 68 | 5 years | |
| Les Kaplan | M | 73 | 18 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Davis
- Personal Network